REVIVA PHARMACEUTICALS HOLDI (RVPH)

US76152G1004 - Common Stock

1.71  -0.11 (-6.3%)

After market: 1.7087 0 (-0.08%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-2-29)		 2019
(2019-2-28)
ASSETS
Current Assets
Cash
18.52M29.69M70.00K310.00K
Other Current Assets
400.00K1.72M70.00K90.00K
Total Current Assets
18.92M31.40M140.00K400.00K
 
Non-Current Assets
PPE Net
N/AN/A0.00N/A
Investments And Advances
N/AN/A60.88M65.24M
Other Non-Current Assets
N/AN/A1.82KN/A
Total Non-Current Assets
0.000.0060.88M65.25M
 
TOTAL ASSETS
18.92M31.40M61.02M65.65M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.00
Accrued Expenses
2.52M1.84M320.00KN/A
Accounts Payable
3.52M510.00K300.00K20.00K
Total Current Liabilities
6.04M2.34M300.00K20.00K
 
Non-Current Liabilities
Long Term Debt
0.000.00750.00K0.00
Other Non-Current Liabilities
570.00K370.00K2.21M2.21M
Total Non-Current Liabilities
570.00K380.00K2.96M2.22M
 
TOTAL LIABILITIES
6.61M2.72M3.26M2.24M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-91.17M-66.83M1.19M570.00K
Additional Paid In Capital
103.49M95.52M63.77MN/A
Common Shares
0.000.0056.57M62.84M
Other Shareholders' Equity
N/AN/A-58.31MN/A
Shares Outstanding
20.45M14.43M7.67M8.27M
Tangible Book Value per Share
0.601.997.537.67
Total Shareholders' Equity
12.32M28.69M57.76M63.41M
 
TOTAL LIABILITIES AND EQUITY
18.92M31.40M61.02M65.65M
 
Statistics
Debt/Equity
N/AN/A0.01N/A
Current Ratio
3.1313.420.4720.00
Return On Assets (ROA)
-128.65%-27.13%1.02%0.87%
Return On Equity (ROE)
-197.56%-29.70%1.07%0.90%

All data in USD

Charts